Aprea Therapeutics Inc. (NASDAQ: APRE)
$3.6600
+0.0400 ( +3.68% ) 4.1K
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Market Data
Open
$3.6600
Previous close
$3.6200
Volume
4.1K
Market cap
$20.49M
Day range
$3.5800 - $3.7650
52 week range
$2.1501 - $8.8465
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
s-3 | Registration statements | 8 | Jan 26, 2024 |
8-k | 8K-related | 12 | Jan 26, 2024 |